BHC today
$8.25-$0.10 (-1.20%)close Nov 12, 2026Trend
DailyUptrend (confirmed)
4 hourLeaning Bearish
1 hourExpanding
15 minStrong Bearish
5 minBearish
Daily trend turns down below $5.54
Key levels
Resistance$9.04
Resistance$8.28
Support$7.65
Support$6.99
Latest news & SEC filings
AnalystBarclays keeps Equal-Weight on Bausch Health, lifts target to $9
AnalystBarclays keeps Hold rating on Bausch Health, lifts price target
All BHC news →About Bausch Health
Bausch Health develops, makes, and sells prescription medicines, generic drugs, over-the-counter remedies, and aesthetic treatment devices. Its main areas of focus include digestive and liver conditions, brain and nerve disorders, and skin diseases. The company runs five business segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. It serves patients, doctors, and aesthetic practitioners across roughly 90 countries.
Based on the company's 10-K filed Feb 19, 2026.
NYSE · Healthcare
Bausch Health Companies Inc. (BHC)
What Is the Price Target for BHC?
SEPT Low Target
$8.00
SEPT Mid Target
$9.00
SEPT High Target
$10.00
Analyst Consensus
$9.00
Is BHC a Buy or Sell Right Now?
Thesis
- •Revenue growing 6.7% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for BHC.
Start Free Trial →Is BHC Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, Analyst Consensus
Fair Value
$28.75
16
Moat Score
NONE
7/9
Piotroski Score
0.3
Altman Z-Score
What Is Smart Money Doing with BHC?
Insider Signal
SELLING
0 buys / 4 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| WECHSLER AMY B | director | Buy | 45,871 | - | May 22, 2026 |
| ROBERTS EIRY | director | Buy | 45,871 | - | May 22, 2026 |
| POWER ROBERT N | director | Buy | 45,871 | - | May 22, 2026 |
| Paulson John | director | Buy | 45,871 | - | May 22, 2026 |
| LEUNG SANDRA | director | Buy | 45,871 | - | May 22, 2026 |
| Lee Frank D. | director | Buy | 45,871 | - | May 22, 2026 |
| KAVANAGH SARAH B | director | Buy | 45,871 | - | May 22, 2026 |
| GOETTLER MICHAEL | director | Buy | 45,871 | - | May 22, 2026 |
| Garcia Christian A | director | Buy | 45,871 | - | May 22, 2026 |
| Lee Frank D. | director | Sale | 24,456 | $133K | May 19, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →BHC Growth Story
Revenue YoY
6.7%
3yr Revenue CAGR
8.1%
EPS Growth YoY
423.08%
FCF Growth YoY
-20.4%
Revenue Trend
STABLE
Dark Pool Trades for BHC
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for BHC, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:26:37 | $8.25 | 54,351 | $$448K | BUY |
| 22:24:27 | $8.25 | 46,181 | $$381K | BUY |
| 21:00:53 | $8.25 | 4,314 | $$36K | SELL |
| 21:00:53 | $8.25 | 3,000 | $$25K | SELL |
| 21:00:53 | $8.25 | 5,276 | $$44K | SELL |
5 dark pool trades shown · $$933K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for BHC
PREVIEWSEPT Investing provides real-time options flow tracking for BHC, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $9 | Nov 20 | 8 | $$65 | 13 | SWEEP |
| PUT | $9 | Nov 20 | 8 | $$6700 | 100 | BLOCK |
| PUT | $9 | Nov 20 | 8 | $$7200 | 100 | BLOCK |
| PUT | $9 | Nov 20 | 8 | $$4260 | 60 | SWEEP |
| CALL | $8.5 | Nov 13 | 1 | $$600 | 100 | BLOCK |
5 options trades shown · 40% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Bausch Health Companies Inc. (BHC) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (4 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →BHC — frequently asked questions
What is BHC stock price today?
Bausch Health Companies Inc. (BHC) is at $8.25, down 1.20% (-$0.10) at the Nov 12, 2026 close.
Why is BHC stock moving today?
Latest BHC news — Nov 11, 2026: Barclays keeps Equal-Weight on Bausch Health, lifts target to $9 · Nov 11, 2026: Barclays keeps Hold rating on Bausch Health, lifts price target
What is the BHC price target?
The average analyst price target for BHC is $9.00, ranging from $8 to $10, based on 2 analysts. Latest: RBC Capital maintains on Oct 29, 2026.
What do analysts rate BHC?
Analyst ratings for BHC: 0 Buy, 7 Hold, 0 Sell — consensus Hold.
Did BHC beat earnings?
BHC last reported on Oct 28, 2026: EPS $0.48 vs $1.25 expected — a miss of 61.6%.
Does BHC pay a dividend?
BHC does not currently pay a dividend.
How much debt does BHC have?
Bausch Health Companies Inc. reported $20.6B of debt and $2.5B of cash (Sep 30, 2026).
What are BHC support and resistance levels?
Support: $7.65, $6.99, $6.22. Resistance: $8.28, $9.04, $9.85.
What are insiders doing with BHC?
Insider activity: SELLING, 0 buys and 4 sells in the last 90 days.
What is the latest news on BHC?
Nov 11, 2026: Barclays keeps Equal-Weight on Bausch Health, lifts target to $9 · Nov 11, 2026: Barclays keeps Hold rating on Bausch Health, lifts price target